Overview

Desvenlafaxine for Preventive Treatment of Frequent Episodic Tension-type Headache

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2028-01-01
Target enrollment:
Participant gender:
Summary
To evaluate whether Desvenlafaxine can reduce the frequency and severity of TTH attacks in patients.
Phase:
NA
Details
Lead Sponsor:
Tongji Hospital
Treatments:
Desvenlafaxine Succinate